This Ex Parte Appeal was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on May 20, 2022 and assigned serial number 88817597 by the TTAB.

Plaintiff:
Sparrow Pharmaceuticals, Inc. represented by SEAN D O’BRIEN of MILLER NASH LLP.
Trademark Information: SPARROW PHARMACEUTICALS – US Trademark Serial Number 88817597
View Trademark Status at USPTO
View Trademark Documents at USPTO

********

Prosecution History:
May 20, 2022 – APPEAL TO BOARD
May 24, 2022 – APPEAL ACKNOWLEDGED; CASE REMANDED
May 24, 2022 – INSTITUTED
June 16, 2022 – PROCEEDINGS RESUMED
June 16, 2022 – CORRECTION TO BD ORDER
August 12, 2022 – APPELLANT REQ FOR REMAND
August 18, 2022 – JURISDICTION RESTORED/REMANDED TO EXAMINER
August 26, 2022 – RECON DENIED
September 02, 2022 – PROCEEDINGS RESUMED
November 23, 2022 – BD DECISION: DISMISSED FOR FAILURE TO FILE BRIEF
January 10, 2023 – TERMINATED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.